As of 2026-02-11, the EV/EBITDA ratio of Editas Medicine Inc (EDIT) is -0.58. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. EDIT's latest enterprise value is 67.18 mil USD. EDIT's TTM EBITDA according to its financial statements is -116.01 mil USD. Dividing these 2 quantities gives us the above EDIT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.6x - 15.5x | 15.0x |
| Forward P/E multiples | 13.1x - 17.5x | 14.9x |
| Fair Price | (16.28) - (17.31) | (16.71) |
| Upside | -1014.8% - -1072.2% | -1038.5% |
| Date | EV/EBITDA |
| 2026-02-10 | -0.58 |
| 2026-02-09 | -0.60 |
| 2026-02-06 | -0.61 |
| 2026-02-05 | -0.48 |
| 2026-02-04 | -0.72 |
| 2026-02-03 | -0.81 |
| 2026-02-02 | -0.77 |
| 2026-01-30 | -0.76 |
| 2026-01-29 | -0.81 |
| 2026-01-28 | -0.81 |
| 2026-01-27 | -0.86 |
| 2026-01-26 | -0.81 |
| 2026-01-23 | -0.90 |
| 2026-01-22 | -1.08 |
| 2026-01-21 | -0.87 |
| 2026-01-20 | -0.78 |
| 2026-01-16 | -0.79 |
| 2026-01-15 | -0.84 |
| 2026-01-14 | -0.95 |
| 2026-01-13 | -0.84 |
| 2026-01-12 | -0.87 |
| 2026-01-09 | -0.82 |
| 2026-01-08 | -0.88 |
| 2026-01-07 | -0.90 |
| 2026-01-06 | -0.88 |
| 2026-01-05 | -0.76 |
| 2026-01-02 | -0.81 |
| 2025-12-31 | -0.81 |
| 2025-12-30 | -0.80 |
| 2025-12-29 | -0.85 |
| 2025-12-26 | -0.91 |
| 2025-12-24 | -0.94 |
| 2025-12-23 | -0.92 |
| 2025-12-22 | -1.04 |
| 2025-12-19 | -1.05 |
| 2025-12-18 | -1.06 |
| 2025-12-17 | -1.08 |
| 2025-12-16 | -1.19 |
| 2025-12-15 | -1.13 |
| 2025-12-12 | -1.21 |
| 2025-12-11 | -1.24 |
| 2025-12-10 | -1.27 |
| 2025-12-09 | -1.13 |
| 2025-12-08 | -1.12 |
| 2025-12-05 | -1.12 |
| 2025-12-04 | -1.13 |
| 2025-12-03 | -1.07 |
| 2025-12-02 | -0.86 |
| 2025-12-01 | -0.92 |
| 2025-11-28 | -1.11 |